This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Tanabe Pharma Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Naoko Ueda: Innovator in Pharmaceutical Chemistry
Introduction
Naoko Ueda is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that have therapeutic applications.
Latest Patents
Naoko Ueda holds 2 patents related to triazine compounds. Her latest patents include a triazine compound salt, which exhibits an inhibitory action against aldosterone synthase. This compound is particularly useful as a drug for preventing or treating primary aldosteronism. The invention details a pharmaceutically acceptable salt of 3-[4-[[trans-4-(acetamino)cyclohexyl]carbamoylmethyl]piperazin-1-yl]-5-(p-tolyl)-1,2,4-triazine, with various salt forms such as hydrobromide, sulfate, succinate, or tosylate.
Career Highlights
Naoko Ueda is currently associated with Tanabe Pharma Corporation, where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new therapeutic agents that address critical health issues.
Collaborations
Naoko collaborates with notable colleagues, including Takafumi Yamagami and Tomofumi Setsuta, contributing to a dynamic research environment that fosters innovation.
Conclusion
Naoko Ueda's contributions to pharmaceutical chemistry highlight her role as a leading inventor in the field. Her innovative work on triazine compounds demonstrates the potential for new treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile